OnKure Therapeutics, Inc.
NASDAQ: OKUR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Nicholas A. Saccomano
- Employees
- 46
- Headquarters
- Boulder, United States
- IPO year
- 2021
- Market cap
- $59.3M
- Website
- https://onkuretherapeutics.com
Loading OKUR…
Loading profile data…Frequently asked questions about OKUR
What does OnKure Therapeutics, Inc. (OKUR) do?
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an...
Where does OKUR trade?
OnKure Therapeutics, Inc. (OKUR) trades on the NASDAQ Global Market.
What sector is OKUR in?
OnKure Therapeutics, Inc. (OKUR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of OnKure Therapeutics, Inc.?
Nicholas A. Saccomano is the chief executive officer of OnKure Therapeutics, Inc. (OKUR).
Where is OnKure Therapeutics, Inc. headquartered?
OnKure Therapeutics, Inc. is headquartered in United States.
Does OKUR pay a dividend?
OnKure Therapeutics, Inc. (OKUR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OKUR go public?
OnKure Therapeutics, Inc. (OKUR) completed its initial public offering in 2021.